Charles R. Ashby

5 ta ish

St. John's University

1. HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies

   Haneen Amawi, Noor Hussein, Chandrabose Karthikeyan +7

   MaqolaOAOchiq kirish20174 iqtibos

   ABIABI:AkademIndex/2026.other.049119

2. An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer Therapy

   Yuzhi Xu, Si‐Yang Liu, Leli Zeng +11

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.124357

3. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance

   Silpa Narayanan, Chao‐Yun Cai, Yehuda G. Assaraf +6

   Sharh maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.127045

4. Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)

   Hang Zhang, Hai‐Wei Xu, Charles R. Ashby +3

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.267557

5. Long non-coding RNAs regulate drug resistance in cancer

   Kaisheng Liu, Lin Gao, Xiaoshi Ma +6

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.288160